Credit Agricole’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-400
Closed -$60K – 700
2021
Q1
$60K Hold
400
– – ﹤0.01% 431
2020
Q4
$61K Sell
400
-1,344
-77% -$192K ﹤0.01% 378
2020
Q3
$236K Buy
+1,744
New +$237K 0.01% 272
2015
Q2
– Sell
-1,845
Closed -$211K – 1432
2015
Q1
$211K Hold
1,845
– – ﹤0.01% 1331
2014
Q4
$192K Hold
1,845
– – ﹤0.01% 1409
2014
Q3
$168K Hold
1,845
– – ﹤0.01% 1390
2014
Q2
$158K Hold
1,845
– – ﹤0.01% 1414
2014
Q1
$145K Hold
1,845
– – ﹤0.01% 1321
2013
Q4
$140K Hold
1,845
– – ﹤0.01% 1343
2013
Q3
$129K Buy
+1,845
New +$121K ﹤0.01% 1359

Other funds holding IBB

Credit Agricole's IBB Position: Q2 2021 in Review

Credit Agricole sold out of iShares Biotechnology ETF (IBB) in Q2 2021, closing a stake of 400 shares — an estimated $60K sold.

Credit Agricole first reported a position in IBB in Q3 2013 and held it in 10 quarters. The position peaked at $236K in Q3 2020. 864 funds tracked by Wall St. Rank hold IBB as of Q2 2021.

  • Credit Agricole reported no remaining iShares Biotechnology ETF position as of Q2 2021 after selling out during the quarter.
  • Credit Agricole sold 400 iShares Biotechnology ETF shares in Q2 2021, an estimated $60K.
  • Credit Agricole first reported a position in iShares Biotechnology ETF in Q3 2013 and held it in 10 quarters.
  • Credit Agricole's iShares Biotechnology ETF position peaked at $236K in Q3 2020.
  • 864 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2021.

Based on Credit Agricole's 13F filing for Q2 2021, filed 10 Aug 2021.